apoptosis
→
ReceivesAction
→
assessed
|
0.77
|
|
cell apoptosis
(subgroup of
apoptosis)
→
ReceivesAction
→
determined by flow cytometry
|
0.68
|
|
apoptosis
→
ReceivesAction
→
measured by annexin v
|
0.60
|
|
gene
→
RelatedTo
→
apoptosis
|
0.60
|
|
apoptosis
→
HasProperty
→
important
|
0.57
|
|
apoptosis
→
ReceivesAction
→
detected by flow cytometry
|
0.57
|
|
apoptosis
→
ReceivesAction
→
induced
|
0.54
|
|
apoptosis
→
ReceivesAction
→
inhibited
|
0.54
|
|
apoptosis
→
CapableOf
→
flow cytometry
|
0.54
|
|
apoptosis
→
ReceivesAction
→
triggered
|
0.53
|
|
apoptosis
→
ReceivesAction
→
determined
|
0.51
|
|
apoptosis
→
ReceivesAction
→
programmed
|
0.49
|
|
apoptosis
→
CapableOf
→
compare with necrosis
|
0.49
|
|
apoptosis
→
CapableOf
→
compare with autophagocytosis
|
0.49
|
|
apoptosis
→
ReceivesAction
→
triggered by internal or external signals
|
0.48
|
|
apoptosis
→
ReceivesAction
→
detected by tunel assay
|
0.48
|
|
apoptosis
→
ReceivesAction
→
induced by etoposide
|
0.47
|
|
apoptosis
→
CapableOf
→
involve caspase
|
0.47
|
|
apoptosis
→
ReceivesAction
→
characterized by chromatin condensation
|
0.47
|
|
apoptosis
→
ReceivesAction
→
induced by serum deprivation
|
0.46
|
|
apoptosis
→
ReceivesAction
→
induced in response
|
0.46
|
|
apoptosis
→
ReceivesAction
→
characterized by dna fragmentation
|
0.45
|
|
apoptosis
→
HasProperty
→
higher
|
0.45
|
|
apoptosis
→
ReceivesAction
→
characterized by cell shrinkage
|
0.45
|
|
apoptosis
→
ReceivesAction
→
induced by chemotherapeutic agents
|
0.45
|
|
apoptosis
→
ReceivesAction
→
induced by trail
|
0.44
|
|
apoptosis
→
CapableOf
→
eliminate cell
|
0.43
|
|
apoptosis
→
ReceivesAction
→
assayed
|
0.43
|
|
apoptosis
→
ReceivesAction
→
induced by cisplatin
|
0.43
|
|
apoptosis
→
ReceivesAction
→
reduced
|
0.43
|
|
apoptosis
→
ReceivesAction
→
increased
|
0.42
|
|
apoptosis
→
ReceivesAction
→
induced by doxorubicin
|
0.42
|
|
apoptosis
→
ReceivesAction
→
observed
|
0.42
|
|
apoptosis
→
ReceivesAction
→
induced by staurosporine
|
0.41
|
|
apoptosis
→
ReceivesAction
→
characterized by membrane blebbing
|
0.41
|
|
apoptosis
→
ReceivesAction
→
induced by cytokine
|
0.41
|
|
apoptosis
→
HasProperty
→
absent
|
0.40
|
|
apoptosis
→
ReceivesAction
→
measured by tunel
|
0.40
|
|
apoptosis
→
DefinedAs
→
cell
|
0.40
|
|
apoptosis
→
ReceivesAction
→
induced by oxidative stress
|
0.40
|
|
compound
→
Causes
→
apoptosis
|
0.40
|
|
apoptosis
→
ReceivesAction
→
induced by tnf
|
0.40
|
|
apoptosis
→
HasProperty
→
consistent
|
0.40
|
|
apoptosis
→
ReceivesAction
→
induced by death receptors
|
0.39
|
|
apoptosis
→
ReceivesAction
→
induced by uv radiation
|
0.39
|
|
apoptosis
→
ReceivesAction
→
detected
|
0.38
|
|
apoptosis
→
CapableOf
→
occur in neuron
|
0.38
|
|
apoptosis
→
HasProperty
→
lower
|
0.38
|
|
apoptosis
→
CapableOf
→
occur in cell
|
0.38
|
|
apoptosis
→
ReceivesAction
→
described in method
|
0.38
|
|
apoptosis
→
ReceivesAction
→
induced by fas
|
0.38
|
|
apoptosis
→
ReceivesAction
→
mediated
|
0.37
|
|
apoptosis
→
ReceivesAction
→
induced by h2o2
|
0.37
|
|
apoptosis
→
ReceivesAction
→
measured by facs
|
0.37
|
|
function
(aspect of
gene)
→
RelatedTo
→
apoptosis
|
0.36
|
|
apoptosis
→
ReceivesAction
→
quantified
|
0.35
|
|
apoptosis
→
ReceivesAction
→
characterized by nuclear fragmentation
|
0.35
|
|
apoptosis
→
ReceivesAction
→
induced by dna damage
|
0.35
|
|
apoptosis
→
CapableOf
→
stain cytometry
|
0.35
|
|
apoptosis
→
ReceivesAction
→
induced by cytotoxic drugs
|
0.35
|
|
apoptosis
→
ReceivesAction
→
mediated by reactive oxygen species
|
0.34
|
|
apoptosis
→
ReceivesAction
→
mediated by mitochondrial altera- tion
|
0.34
|
|
apoptosis
→
ReceivesAction
→
induced by tumor necrosis factor
|
0.34
|
|
apoptosis
→
ReceivesAction
→
induced by radiation
|
0.34
|
|
apoptosis
→
ReceivesAction
→
induced by a variety of stimuli
|
0.34
|
|
apoptosis
→
HasProperty
→
independent
|
0.34
|
|
apoptosis
→
ReceivesAction
→
induced by irradiation
|
0.34
|
|
apoptosis
→
ReceivesAction
→
modulated
|
0.34
|
|
apoptosis
→
ReceivesAction
→
induced by 5-fu
|
0.34
|
|
apoptosis
→
ReceivesAction
→
induced by hydrogen peroxide
|
0.34
|
|
apoptosis
→
CapableOf
→
occur in single cells
|
0.33
|
|
apoptosis
→
ReceivesAction
→
shown in figure
|
0.32
|
|
apoptosis
→
ReceivesAction
→
induced by palmitic acid
|
0.32
|
|
apoptosis
→
ReceivesAction
→
induced by hypericin-mediated pdt
|
0.32
|
|
apoptosis
→
ReceivesAction
→
decreased in cell
|
0.32
|
|
apoptosis
→
IsA
→
regulated cell death process
|
0.32
|
|
apoptosis
→
ReceivesAction
→
described in material
|
0.32
|
|
apoptosis
→
ReceivesAction
→
induced by sts
|
0.32
|
|
apoptosis
→
ReceivesAction
→
restored
|
0.32
|
|
apoptosis
→
ReceivesAction
→
mediated by p53
|
0.32
|
|
apoptosis
→
ReceivesAction
→
induced by mvaδf1l
|
0.32
|
|
apoptosis
→
ReceivesAction
→
increased in cell
|
0.32
|
|
apoptosis
→
ReceivesAction
→
induced by adriamycin
|
0.30
|
|
apoptosis
→
ReceivesAction
→
induced in embodiment
|
0.30
|
|
apoptosis
→
CapableOf
→
confer advantage
|
0.30
|
|
apoptosis
→
ReceivesAction
→
induced by cannabidiol
|
0.30
|
|
apoptosis
→
ReceivesAction
→
induced by rita
|
0.30
|
|
apoptosis
→
ReceivesAction
→
induced by t. gondii
|
0.30
|
|
apoptosis
→
HasProperty
→
detrimental
|
0.29
|
|
apoptosis
→
ReceivesAction
→
induced by hypoxia
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by growth factor deprivation
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by camptothecin
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by actinomycin d
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by paclitaxel
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by ifn-γ
|
0.28
|
|
apoptosis
→
CapableOf
→
occur through intrinsic pathway
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by oxaliplatin
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by fasl
|
0.28
|
|
apoptosis
→
CapableOf
→
use propidium iodide
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by mva
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by ox-ldl
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced in jurkat cells
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by isolate
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by taxane
|
0.28
|
|
apoptosis
→
ReceivesAction
→
induced by bix-01294
|
0.28
|
|
apoptosis
→
ReceivesAction
→
triggered by neglect
|
0.28
|
|
apoptosis
→
CapableOf
→
remain confined
|
0.28
|
|
apoptosis
→
CapableOf
→
induce agent
|
0.25
|
|
apoptosis
→
ReceivesAction
→
mediated by cleavage of bid
|
0.25
|
|
apoptosis
→
ReceivesAction
→
mediated by multiple papain-like lysosomal cathepsins
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by thapsigargin
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by stz
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by pdt
|
0.25
|
|
apoptosis
→
CapableOf
→
produce long-term or permanent results
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by l. interrogans
|
0.25
|
|
apoptosis
→
ReceivesAction
→
characterized by morphological changes
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by abt-737
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by pa
|
0.25
|
|
apoptosis
→
CapableOf
→
induce protein
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by co
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by dexamethasone
|
0.25
|
|
apoptosis
→
ReceivesAction
→
mediated by trail receptor
|
0.25
|
|
apoptosis
→
HasProperty
→
immunogenic
|
0.25
|
|
apoptosis
→
ReceivesAction
→
characterized by formation of apoptotic bodies
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by hid
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by docetaxel
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by cytosine arabinoside
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by evodiamine
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by evo/hp-β-cd complexes
|
0.25
|
|
apoptosis
→
ReceivesAction
→
regulated by bcl-2
|
0.25
|
|
apoptosis
→
CapableOf
→
occur in human scis
|
0.25
|
|
apoptosis
→
ReceivesAction
→
produced by the combination treatment
|
0.25
|
|
apoptosis
→
CapableOf
→
use hoechst
|
0.25
|
|
apoptosis
→
CapableOf
→
share common stimuli
|
0.25
|
|
apoptosis
→
ReceivesAction
→
correlated with drug concentrations
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by heat stress
|
0.25
|
|
apoptosis
→
CapableOf
→
use nuclear dyes
|
0.25
|
|
apoptosis
→
CapableOf
→
remodel tissue
|
0.25
|
|
apoptosis
→
ReceivesAction
→
associated with emt
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by il-1β
|
0.25
|
|
apoptosis
→
ReceivesAction
→
induced by nampt inhibitors
|
0.25
|
|
apoptosis
→
CapableOf
→
limit viral replication
|
0.25
|
|
cell apoptosis
(subgroup of
apoptosis)
→
CapableOf
→
detected by annexin v
|
0.25
|
|
cell apoptosis
(subgroup of
apoptosis)
→
CapableOf
→
detected by pi staining methods
|
0.25
|
|
transcript
→
RelatedTo
→
apoptosis
|
0.25
|
|
apoptosis
→
CapableOf
→
produce cell fragments
|
0.24
|
|
apoptosis
→
ReceivesAction
→
characterized by nuclear condensation
|
0.22
|
|
apoptosis
→
HasProperty
→
defective
|
0.22
|
|
apoptosis
→
ReceivesAction
→
denoted by nuclear blebbing
|
0.19
|
|
apoptosis
→
ReceivesAction
→
observed in contrast
|
0.18
|
|
apoptosis
→
ReceivesAction
→
coupled with killing of intracellular bacillus calmette-guerin
|
0.16
|
|
apoptosis
→
HasProperty
→
silent
|
0.16
|
|
apoptosis
→
ReceivesAction
→
identified in brain
|
0.16
|
|
apoptosis
→
ReceivesAction
→
identified in spinal cord injury
|
0.16
|
|
liver
→
HasSubevent
→
apoptosis
|
0.16
|
|
telomere
→
HasSubevent
→
apoptosis
|
0.16
|
|